Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

10.43
+0.23502.31%
Volume:653.64K
Turnover:6.73M
Market Cap:1.90B
PE:-102.20
High:10.44
Open:10.15
Low:10.08
Close:10.19
52wk High:11.33
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:0.76
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-195.26
PE(LYR):3,250.70

Loading ...

Xeris Biopharma is Maintained at Overweight by Barclays

Dow Jones
·
Oct 06

Xeris Biopharma price target raised to $14 from $12 at Barclays

TIPRANKS
·
Oct 06

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA), Xeris Pharmaceuticals (XERS) and Incyte (INCY)

TIPRANKS
·
Oct 06

Xeris Biopharma Grants Inducement Equity Awards Covering 352,170 Shares to 60 New Employees

Reuters
·
Oct 03

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Oct 03

Xeris Biopharma Chief Legal Officer Beth Hecht Disposes of 16,666 Shares Worth $156,797

Reuters
·
Oct 03

Deals of the Day-Mergers and Acquisitions

Reuters
·
Sep 30

Xeris Biopharma COO Kevin McCulloch Sells $250,000 in Common Shares

Reuters
·
Sep 30

Xeris Biopharma Rises on Report of Lundbeck Takeover Interest

Reuters
·
Sep 30

Lundbeck exploring acquisition of Xeris, Bloomberg reports

TIPRANKS
·
Sep 30

Lundbeck is Said to Express Interest in Buying Xeris Biopharma - Bloomberg News

THOMSON REUTERS
·
Sep 30

Market Chatter: Lundbeck Said to Explore Potential Xeris Biopharma Acquisition

MT Newswires Live
·
Sep 30

Xeris Biopharma tells Bloomberg ‘not for sale’

TIPRANKS
·
Sep 30

Lundbeck Said to Explore Potential Xeris Biopharma Acquisition, Bloomberg Reports

MT Newswires Live
·
Sep 30

H.C. Wainwright Remains a Buy on Xeris Pharmaceuticals (XERS)

TIPRANKS
·
Sep 22

Xeris Biopharma is Maintained at Outperform by Leerink Partners

Dow Jones
·
Sep 10

Analysts Conflicted on These Healthcare Names: Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS)

TIPRANKS
·
Sep 10

Xeris Biopharma price target raised to $16 from $12 at Leerink

TIPRANKS
·
Sep 10

Medmix Drug Delivery Unit Partners with Xeris on XP-8121 D-Flex Pen Injector Development

Reuters
·
Sep 10

Xeris Biopharma hosts webinar on XP-8121 development program

TIPRANKS
·
Sep 09